TW200504030A - Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof - Google Patents
Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereofInfo
- Publication number
- TW200504030A TW200504030A TW093116702A TW93116702A TW200504030A TW 200504030 A TW200504030 A TW 200504030A TW 093116702 A TW093116702 A TW 093116702A TW 93116702 A TW93116702 A TW 93116702A TW 200504030 A TW200504030 A TW 200504030A
- Authority
- TW
- Taiwan
- Prior art keywords
- preparation
- compositions containing
- benzimidazole derivatives
- compounds
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Abstract
Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4 and Z are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0301699A SE0301699D0 (en) | 2003-06-10 | 2003-06-10 | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200504030A true TW200504030A (en) | 2005-02-01 |
Family
ID=29212433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093116702A TW200504030A (en) | 2003-06-10 | 2004-06-10 | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
Country Status (24)
Country | Link |
---|---|
US (1) | US7517898B2 (en) |
EP (1) | EP1636193A1 (en) |
JP (1) | JP2006527247A (en) |
KR (1) | KR20060017863A (en) |
CN (2) | CN1805940A (en) |
AR (1) | AR044665A1 (en) |
AU (1) | AU2004245296B2 (en) |
BR (1) | BRPI0411226A (en) |
CA (1) | CA2528924A1 (en) |
CO (1) | CO5660261A2 (en) |
IL (1) | IL172027A0 (en) |
IS (1) | IS8220A (en) |
MX (1) | MXPA05013050A (en) |
MY (1) | MY139676A (en) |
NO (1) | NO20060146L (en) |
NZ (1) | NZ543632A (en) |
RU (1) | RU2329254C2 (en) |
SA (1) | SA04250161B1 (en) |
SE (1) | SE0301699D0 (en) |
TW (1) | TW200504030A (en) |
UA (1) | UA83832C2 (en) |
UY (1) | UY28357A1 (en) |
WO (1) | WO2004108688A1 (en) |
ZA (1) | ZA200509869B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0302570D0 (en) * | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
SE0302573D0 (en) * | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
KR101269869B1 (en) | 2004-09-24 | 2013-06-07 | 네오메드 인스티튜트 | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
WO2007013848A1 (en) * | 2005-07-29 | 2007-02-01 | Astrazeneca Ab | Process for the preparation of geminal ((difluorocycloalkyl)methyl) amines. |
EP1988076A4 (en) | 2006-02-20 | 2013-09-04 | Astellas Pharma Inc | Amide derivative or salt thereof |
TW200745049A (en) | 2006-03-23 | 2007-12-16 | Astrazeneca Ab | New crystalline forms |
TW200808769A (en) * | 2006-04-18 | 2008-02-16 | Astrazeneca Ab | Therapeutic compounds |
TW200808772A (en) * | 2006-06-13 | 2008-02-16 | Astrazeneca Ab | Therapeutic compounds |
US20080139846A1 (en) * | 2006-09-01 | 2008-06-12 | Astrazeneca Ab | New Process 298 |
WO2008153701A1 (en) * | 2007-05-24 | 2008-12-18 | Schering Corporation | Compounds for inhibiting ksp kinesin activity |
JP2011507851A (en) * | 2007-12-19 | 2011-03-10 | ザ スクリプス リサーチ インスティチュート | Benzimidazoles and analogs as Rho kinase inhibitors |
US20110086853A1 (en) * | 2009-10-08 | 2011-04-14 | William Brown | Therapeutic Compounds |
MX337662B (en) * | 2010-10-06 | 2016-03-14 | Glaxosmithkline Llc | Benzimidazole derivatives as pi3 kinase inhibitors. |
EP2897939B1 (en) | 2012-09-21 | 2017-02-01 | Sanofi | Benzoimidazole-carboxylic acid amide derivatives for treating metabolic or cardiovascular diseases |
AU2016233568A1 (en) | 2015-03-13 | 2017-10-05 | Forma Therapeutics, Inc. | Alpha-cinnamide compounds and compositions as HDAC8 inhibitors |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9121776D0 (en) | 1991-10-14 | 1991-11-27 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives and process for preparation thereof |
JP3295277B2 (en) * | 1994-06-01 | 2002-06-24 | 呉羽化学工業株式会社 | Antinephrotic agent and benzimidazole derivative |
JP3063162B2 (en) * | 1995-12-28 | 2000-07-12 | 藤沢薬品工業株式会社 | Benzimidazole derivatives |
US6348032B1 (en) * | 1998-11-23 | 2002-02-19 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with benzimidazole derivatives |
FR2789079B3 (en) * | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | PYRAZOLECARBOXYLIC ACID DERIVATIVE, ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
JP2001247550A (en) * | 1999-12-27 | 2001-09-11 | Japan Tobacco Inc | Condensed ring compound and its medicinal use |
PA8535601A1 (en) * | 2000-12-21 | 2002-11-28 | Pfizer | BENZIMIDAZOL AND PIRIDILIMIDAZOL DERIVATIVES AS LIGANDOS FOR GABAA |
SE0101387D0 (en) * | 2001-04-20 | 2001-04-20 | Astrazeneca Ab | Novel compounds |
US7196095B2 (en) * | 2001-06-25 | 2007-03-27 | Merck & Co., Inc. | (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds |
TWI231757B (en) | 2001-09-21 | 2005-05-01 | Solvay Pharm Bv | 1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity |
WO2003053938A1 (en) * | 2001-12-20 | 2003-07-03 | Novo Nordisk A/S | Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten |
SE0203070D0 (en) * | 2002-10-16 | 2002-10-16 | Astrazeneca Ab | Novel compounds |
SE0301698D0 (en) * | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
-
2003
- 2003-06-10 SE SE0301699A patent/SE0301699D0/en unknown
-
2004
- 2004-06-08 MY MYPI20042197A patent/MY139676A/en unknown
- 2004-06-09 CA CA002528924A patent/CA2528924A1/en not_active Abandoned
- 2004-06-09 AU AU2004245296A patent/AU2004245296B2/en not_active Ceased
- 2004-06-09 RU RU2005138371/04A patent/RU2329254C2/en not_active IP Right Cessation
- 2004-06-09 MX MXPA05013050A patent/MXPA05013050A/en active IP Right Grant
- 2004-06-09 EP EP04736410A patent/EP1636193A1/en not_active Withdrawn
- 2004-06-09 KR KR1020057023712A patent/KR20060017863A/en not_active Application Discontinuation
- 2004-06-09 CN CNA2004800163272A patent/CN1805940A/en active Pending
- 2004-06-09 US US10/557,813 patent/US7517898B2/en not_active Expired - Fee Related
- 2004-06-09 NZ NZ543632A patent/NZ543632A/en unknown
- 2004-06-09 BR BRPI0411226-1A patent/BRPI0411226A/en not_active IP Right Cessation
- 2004-06-09 CN CNA2008101360526A patent/CN101328151A/en active Pending
- 2004-06-09 JP JP2006516384A patent/JP2006527247A/en active Pending
- 2004-06-09 WO PCT/GB2004/002427 patent/WO2004108688A1/en active Application Filing
- 2004-06-10 AR ARP040102016A patent/AR044665A1/en not_active Application Discontinuation
- 2004-06-10 UY UY28357A patent/UY28357A1/en unknown
- 2004-06-10 TW TW093116702A patent/TW200504030A/en unknown
- 2004-06-12 SA SA04250161A patent/SA04250161B1/en unknown
- 2004-09-06 UA UAA200511189A patent/UA83832C2/en unknown
-
2005
- 2005-11-17 IL IL172027A patent/IL172027A0/en unknown
- 2005-12-05 CO CO05123385A patent/CO5660261A2/en not_active Application Discontinuation
- 2005-12-05 ZA ZA200509869A patent/ZA200509869B/en unknown
-
2006
- 2006-01-04 IS IS8220A patent/IS8220A/en unknown
- 2006-01-10 NO NO20060146A patent/NO20060146L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UY28357A1 (en) | 2005-01-31 |
EP1636193A1 (en) | 2006-03-22 |
JP2006527247A (en) | 2006-11-30 |
MXPA05013050A (en) | 2006-03-02 |
CN101328151A (en) | 2008-12-24 |
BRPI0411226A (en) | 2006-07-18 |
NZ543632A (en) | 2009-02-28 |
SA04250161B1 (en) | 2009-04-18 |
AR044665A1 (en) | 2005-09-21 |
US7517898B2 (en) | 2009-04-14 |
AU2004245296A1 (en) | 2004-12-16 |
RU2005138371A (en) | 2006-07-27 |
ZA200509869B (en) | 2006-11-29 |
KR20060017863A (en) | 2006-02-27 |
CN1805940A (en) | 2006-07-19 |
IL172027A0 (en) | 2011-08-01 |
NO20060146L (en) | 2006-03-07 |
RU2329254C2 (en) | 2008-07-20 |
SE0301699D0 (en) | 2003-06-10 |
IS8220A (en) | 2006-01-04 |
US20070060583A1 (en) | 2007-03-15 |
WO2004108688A1 (en) | 2004-12-16 |
CO5660261A2 (en) | 2006-07-31 |
UA83832C2 (en) | 2008-08-26 |
MY139676A (en) | 2009-10-30 |
AU2004245296B2 (en) | 2008-05-22 |
CA2528924A1 (en) | 2004-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009011997A (en) | Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals. | |
TW200716628A (en) | Novel compounds | |
MY140630A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0401342D0 (en) | Therapeutic compounds | |
TW200504029A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0402762D0 (en) | Indazole sulphonamide derivatives | |
SE0300908D0 (en) | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | |
TW200626581A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
TW200504030A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0302570D0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0302572D0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
TW200504059A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
SE0302571D0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0400027D0 (en) | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof | |
TW200510312A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
TW200500356A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
SE0400285D0 (en) | Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof | |
MXPA05007483A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof. | |
TW200510313A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
SE0301698D0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0402763D0 (en) | Nitro indazole derivatives | |
TW200512192A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
TW200505859A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
TW200626582A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
TW200504018A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |